News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
U.S. Clears Novartis AG Malaria Drug, Awards Voucher
April 8, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON, April 8 (Reuters) - U.S. health officials approved a Novartis AG (NOVN.VX) malaria drug on Wednesday and awarded the company a voucher to speed approval of a future medicine.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Novartis
MORE ON THIS TOPIC
Government
CDER Employees Leave FDA in Droves Amid HHS Overhaul
July 17, 2025
·
2 min read
·
Tristan Manalac
Neuropsychiatric disorders
Otsuka, Lundbeck’s PTSD Bid for Rexulti Hits Speedbump as FDA Questions Efficacy
July 17, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff
July 16, 2025
·
2 min read
·
Heather McKenzie
Antibody-drug conjugate
GSK’s Blenrep DREAMMs Turn Fitful as FDA Questions Comeback in Multiple Myeloma
July 16, 2025
·
2 min read
·
Tristan Manalac
